Alane Koki
Impact in
- Pharmacology top 0.05%
- Inflammatory mediators and NSAID effects
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 29
- Inflammatory mediators and NSAID effects 29
- Pharmacogenetics and Drug Metabolism 2
- Genetics 19
- Estrogen and related hormone effects 19
- Co-authors
- Jaime L. Masferrer (20 shared papers)B. Mark Woerner (10 shared papers)K. Leahy (6 shared papers)Andrew J. Dannenberg (6 shared papers)Karen Seibert (8 shared papers)Robert A. Soslow (5 shared papers)Ben S. Zweifel (5 shared papers)Kanwar Nasir M. Khan (5 shared papers)
- Journals
- Molecular Carcinogenesis (2 papers)Oncogene (2 papers)Advances in experimental medicine and biology (2 papers)Scandinavian Journal of Gastroenterology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Alane Koki
38 papers receiving 6.0k citations
Alane Koki's Hit Papers
Peers
Comparison fields: 5 of 120
- Pharmacology 3.3k
- Biochemistry 517
- Genetics 1.7k
- Cancer Research 824
- Psychiatry and Mental health 760
Countries citing papers authored by Alane Koki
This map shows the geographic impact of Alane Koki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alane Koki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alane Koki more than expected).
Fields of papers citing papers by Alane Koki
This network shows the impact of papers produced by Alane Koki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alane Koki. The network helps show where Alane Koki may publish in the future.
Co-authors
The 25 scholars most cited alongside Alane Koki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Hit paper breakdown → | 2000 | 1109 |
| 2 | COX-2 is expressed in human pulmonary, colonic, and mammary tumors Hit paper breakdown → | 2000 | 746 |
| 3 | Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Hit paper breakdown → | 1999 | 603 |
| 4 | Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Hit paper breakdown → | 1999 | 603 |
| 5 | Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. | 2002 | 375 |
| 6 | Cyclooxygenase-2 is overexpressed in human cervical cancer. | 2001 | 295 |
| 7 | 2002 | 270 | |
| 8 | Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. | 1999 | 243 |
| 9 | Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. | 2000 | 218 |
| 10 | 2002 | 199 | |
| 11 | 2005 | 174 | |
| 12 | 1998 | 168 | |
| 13 | 2000 | 159 | |
| 14 | 2003 | 136 | |
| 15 | 1999 | 132 | |
| 16 | 2002 | 117 | |
| 17 | 2004 | 101 | |
| 18 | 1999 | 99 | |
| 19 | 2001 | 60 | |
| 20 | Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. | 2002 | 60 |
About Alane Koki
Alane Koki is a scholar working on Pharmacology, Genetics, Psychiatry and Mental health, Biochemistry and Molecular Biology, having authored 38 papers that have together received 6.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (29 papers), Estrogen and related hormone effects (19 papers), Cancer, Stress, Anesthesia, and Immune Response (12 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Gene expression and cancer classification (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Advanced Proteomics Techniques and Applications (1 paper) and Osteoarthritis Treatment and Mechanisms (1 paper). The work is most often cited by research in Pharmacology (3.3k citations), Biochemistry (517 citations), Genetics (1.7k citations), Cancer Research (824 citations) and Psychiatry and Mental health (760 citations). Alane Koki has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Jaime L. Masferrer, B. Mark Woerner, K. Leahy, Andrew J. Dannenberg, Karen Seibert, Robert A. Soslow, Ben S. Zweifel, Kanwar Nasir M. Khan, D A Edwards and Steven L. Settle. Their work appears in journals such as Molecular Carcinogenesis, Oncogene, Advances in experimental medicine and biology, Scandinavian Journal of Gastroenterology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.